Edges in Network
Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
Node | SLC34A3 |
Upstream (Parents) |
---|
(<<) GSK3A → SLC34A3 |
(<<) UTS2R → SLC34A3 |
Downstream (Children) |
---|
SLC34A3 → BCL6 (>>) |
SLC34A3 → CCDC108 (>>) |
SLC34A3 → CDH22 (>>) |
SLC34A3 → CYP1A2 (>>) |
SLC34A3 → CYP4F2 (>>) |
SLC34A3 → E2F4 (>>) |
SLC34A3 → ENO3 (>>) |
SLC34A3 → EXOC3L2 (>>) |
SLC34A3 → FER1L4 (>>) |
SLC34A3 → FLJ35390 (>>) |
SLC34A3 → GALR3 (>>) |
SLC34A3 → GSK3B (>>) |
SLC34A3 → HDAC11 (>>) |
SLC34A3 → HDAC8 (>>) |
SLC34A3 → IL23A (>>) |
SLC34A3 → IL27 (>>) |
SLC34A3 → INE1 (>>) |
SLC34A3 → KLK3 (>>) |
SLC34A3 → KRT75 (>>) |
SLC34A3 → LCE3D (>>) |
SLC34A3 → LOC100130557 (>>) |
SLC34A3 → LOC100131581 (>>) |
SLC34A3 → LOC92659 (>>) |
SLC34A3 → MMP14 (>>) |
SLC34A3 → MMP19 (>>) |
SLC34A3 → NDOR1 (>>) |
SLC34A3 → NLGN4Y (>>) |
SLC34A3 → PIK3CB (>>) |
SLC34A3 → PLA2G6 (>>) |
SLC34A3 → PLCD3 (>>) |
SLC34A3 → SEMA5B (>>) |
SLC34A3 → SPRR2G (>>) |
SLC34A3 → ST3GAL6 (>>) |
SLC34A3 → T (>>) |
SLC34A3 → THEM5 (>>) |
SLC34A3 → TMEM88 (>>) |
SLC34A3 → TMPRSS11D (>>) |
SLC34A3 → TPSG1 (>>) |
SLC34A3 → UAP1 (>>) |
SLC34A3 → WNT7A (>>) |
SLC34A3 → ZNF205 (>>) |